Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.1 USD | +0.96% | +2.98% | +15.11% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 1.66B | |
+9.43% | 114B | |
+11.55% | 104B | |
-14.07% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.03% | 17.89B | |
+6.85% | 14.28B | |
+35.45% | 12.55B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Transcript : Soleno Therapeutics, Inc. - Special Call